Miguel Ángel González Jasso
Miguel Ángel González Jasso has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- César Castro Reyes1 shared publication
- Felipe Arturo Morales Martínez
University Center for Reproductive Medicine Autonomous University of Nuevo León Monterrey México
1 shared publication - Jesús Zacarías Villarreal-Pérez
Universidad Autonóma de Nuevo León
1 shared publication - Karina Raygoza Cortez
Human Nature Lab, Yale University, New Haven, Connecticut, USA
1 shared publication - René Rodríguez-Gutiérrez
Plataforma INVEST Medicina UANL-KER Unit Mayo Clinic (KER Unit Mexico), Universidad Autónoma de Nuevo León Facultad de Medicina, Monterrey, Mexico
1 shared publication - Selene M. Garcia Luna
Department of Entomology, Texas A&M University, College Station, TX 77843, USA
1 shared publication
Latest Publications
- 1 December 2025
- Published by Colegio de Reproduccion Asistida de Mexico, S.C. in The Journal of Reproduction
- Vol. 3 (1) , 29-34
Pregnancy after treatment of an azoospermic male with adrenal congenital Hyperplas
A 31-year-old male with congenital adrenal hyperplasia (CAH) due to a 21-hydroxylase deficiency attended the Endocrinology Department of the University Hospital for fertility assessment. Physical examination was normal and the testicular ultrasound showed the presence of intra-testicular adrenal residues and normal testicular volume. The semen analysis reported azoospermia and was positive for a fructose qualitative test. As for the hormonal analysis, cortisol was within normal range, 17- alpha-hydroxyprogesterone (17-αOHP) and adrenocorticotropin (ACTH) were elevated while follicle-stimulating hormone (FSH), luteinizing hormone (LH) and total testosterone were low. Daily intake of 20 mg of oral hydrocortisone and 0.25 dexamethasone was initiated. After three months, the patient reported asthenia and decreased libido. Cortisol decreased close to normal levels, and 17-αOHP and ACTH also decreased although those did not reach normal levels. FSH and LH increased to normal range values. Androstenedione and prolactin were elevated. At this evaluation, the dehydroepiandrosterone (DHEA) was diminished at 27.4 mg/dl and the daily hydrocortisone dose was increased to 25 mg. After 5 months, cortisol decreased and 17-αOHP remained elevated, inhibin B was within the normal range at 51 pg/ml, and sperm cells were absent on the semen evaluation. The patient was referred to a reproductive biologist for azoospermia evaluation and management. The study of the female partner was normal regarding physical, hormonal, and tubal-uterine factors. To stimulate spermatogenesis, treatment with human chorionic gonadotropin (HCG) and human menopausal gonadotropin (HMG) was given for three months, but azoospermia persisted. Therefore, a testicular biopsy was obtained finding oligoasthenoteratozoospermia and testicular motile sperm were cryopreserved. His 34-year-old female partner was subject to controlled ovarian stimulation with a subcutaneous injection of Human recombinant follicle-stimulating hormone (r-FSH). When at least three follicles reached ≥ 18 mm, the oocyte maturation was co-triggered by 250 UI of choriogonadotropin subcutaneously and follicular aspiration occurred 36 hours later. A total of 20 oocytes were retrieved from which 10 metaphase II oocytes were used for the intracytoplasmic sperm injection (ICSI), and half of them fertilized. Meanwhile, endometrial preparation began for frozen embryo transfer (FET) on day 1 of the menstrual cycle, with 6 mg of estradiol valerate orally for 12 days, after ultrasonography confirmed adequate endometrial thickness, 600 mg per day of vaginal progesterone was administrated 4 days prior the embryo transfer, at which time, two embryos on cleavage stage (day 3) were transferred with a positive pregnancy test two weeks later. The results of the molecular analysis reported a CAH-heterozygous carrier status of the mother so glucocorticoid therapy was started. A non-invasive
- 1 December 2025
- Published by Colegio de Reproduccion Asistida de Mexico, S.C. in The Journal of Reproduction
- Vol. 3 (1) , 29-34
Pregnancy after treatment of an azoospermic male with adrenal congenital Hyperplas
A 31-year-old male with congenital adrenal hyperplasia (CAH) due to a 21-hydroxylase deficiency attended the Endocrinology Department of the University Hospital for fertility assessment. Physical examination was normal and the testicular ultrasound showed the presence of intra-testicular adrenal residues and normal testicular volume. The semen analysis reported azoospermia and was positive for a fructose qualitative test. As for the hormonal analysis, cortisol was within normal range, 17- alpha-hydroxyprogesterone (17-αOHP) and adrenocorticotropin (ACTH) were elevated while follicle-stimulating hormone (FSH), luteinizing hormone (LH) and total testosterone were low. Daily intake of 20 mg of oral hydrocortisone and 0.25 dexamethasone was initiated. After three months, the patient reported asthenia and decreased libido. Cortisol decreased close to normal levels, and 17-αOHP and ACTH also decreased although those did not reach normal levels. FSH and LH increased to normal range values. Androstenedione and prolactin were elevated. At this evaluation, the dehydroepiandrosterone (DHEA) was diminished at 27.4 mg/dl and the daily hydrocortisone dose was increased to 25 mg. After 5 months, cortisol decreased and 17-αOHP remained elevated, inhibin B was within the normal range at 51 pg/ml, and sperm cells were absent on the semen evaluation. The patient was referred to a reproductive biologist for azoospermia evaluation and management. The study of the female partner was normal regarding physical, hormonal, and tubal-uterine factors. To stimulate spermatogenesis, treatment with human chorionic gonadotropin (HCG) and human menopausal gonadotropin (HMG) was given for three months, but azoospermia persisted. Therefore, a testicular biopsy was obtained finding oligoasthenoteratozoospermia and testicular motile sperm were cryopreserved. His 34-year-old female partner was subject to controlled ovarian stimulation with a subcutaneous injection of Human recombinant follicle-stimulating hormone (r-FSH). When at least three follicles reached ≥ 18 mm, the oocyte maturation was co-triggered by 250 UI of choriogonadotropin subcutaneously and follicular aspiration occurred 36 hours later. A total of 20 oocytes were retrieved from which 10 metaphase II oocytes were used for the intracytoplasmic sperm injection (ICSI), and half of them fertilized. Meanwhile, endometrial preparation began for frozen embryo transfer (FET) on day 1 of the menstrual cycle, with 6 mg of estradiol valerate orally for 12 days, after ultrasonography confirmed adequate endometrial thickness, 600 mg per day of vaginal progesterone was administrated 4 days prior the embryo transfer, at which time, two embryos on cleavage stage (day 3) were transferred with a positive pregnancy test two weeks later. The results of the molecular analysis reported a CAH-heterozygous carrier status of the mother so glucocorticoid therapy was started. A non-invasive